Biotechnology

Digital PCR and Real-Time PCR Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs), By Region, And Segment Forecasts, 2025-2034

Global Digital PCR and Real-Time PCR Market Size is valued at USD 8.8 billion in 2024 and is predicted to reach USD 18.9 billion by the year 2034 at an 8.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report:   This market growth is being attributed to an increasing focus on early disease diagnosis due to the rise of infectious diseases globally. A rise in the demand for digital PCR ...

Report ID: 1772  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Cell and Gene Therapy Bio-manufacturing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Equipment, And Software Solutions), Usage (Commercial-Stage Manufacturing And Research-Stage Manufacturing), Application (Upstream Processing, Harvesting, And Downstream Processing), And End-User, By Region, And Segment Forecasts, 2025-2034

Cell and Gene Therapy Bio-Manufacturing Market Size is valued at 13.8 billion in 2024 and is predicted to reach 40.2 billion by the year 2031 at an 11.4% CAGR during the forecast period for 2025-2034. The global cell and gene therapy bio-manufacturing market is advancing. The cell and gene therapy industry is rapidly expanding due to its promise to cure chronic and rare/orphan diseases that previously had few therapeutic choices. The developme...

Report ID: 1692  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Stem Cell Exosome Therapeutic Market Size, Share & Trends Analysis Report By Source Type (MSC, dendritic cells, umbilical MSC, plasma, and others), By Application, By Region, And By Segment Forecasts, 2025-2034

Stem Cell Exosome Therapeutic Market is valued at 17.7 Million in 2024 and is predicted to reach 97.0 Million by the year 2034 at a 18.6%% CAGR during the forecast period for 2025-2034. Exosomes are gaining popularity rapidly as a method to access the therapeutic benefits of stem cells without the complications and difficulties of delivering the cells to patients. Exosomes are sold as diagnostic devices, therapeutic agents, cosmeceuticals, res...

Report ID: 1133  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Exosome Research Market Size, Share & Trends Analysis Report By Products & Services (Kits And Reagents, Instruments And Services), Disease Indications (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, And Infectious Diseases), Applications (Biomarkers, Vaccine Development, Tissue Regeneration) And End Users, Region And Segment Forecasts, 2025-2034

Global Exosome Research Market is valued at USD 65.1 Million in 2024, and it is expected to reach USD 331.7 Million by 2034, with a CAGR of 18.0% during the forecast period of 2025-2034. The demand for exosome research products has grown due to the growing use of specialized testing services such as liquid chromatography-mass spectrometry, RNA sequencing, wet chemistry, gene expressions, and various other testing services. These testing servic...

Report ID: 1810  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables (Antibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing, imaging, and biopsy technology), Application (Breast Cancer, Lung Cancer), End User (Hospitals), By Region, And Segment Forecasts, 2025-2034

The global Cancer Diagnostics market Size is valued at 110.25 billion in 2024 and is predicted to reach 204.49 billion by the year 2031 at a 6.5% CAGR during the forecast period for 2025-2034. One of the essential factors of the Cancer Diagnostics market growth throughout the anticipated period is the rise in cancer cases worldwide. Diagnostic test technological developments are also anticipated to support industry expansion. Additio...

Report ID: 1726  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Protein Design and Engineering Market Size, Share & Trends Analysis Report By Type of Protein Engineering Approach Used (Rational Designing, Directed Evolution, Semi-Rational Designing), By Protein Types (Antibodies, Peptides, Enzymes, Vaccines, Others), By Type of Application (Therapeutics, Diagnostics), By End-Users, By Region, And By Segment Forecasts, 2025-2034

Global Protein Design and Engineering Market Size is valued at USD 6.4 Billion in 2024 and is predicted to reach USD 25.1 Billion by the year 2034  at a 15.0 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing cases of chronic & infectious diseases such as diabetes, cardiovascular conditions, and cancer is driving the protein design and engineering market. Fast adva...

Report ID: 1205  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Isothermal Nucleic Acid Amplification Technology Market Size, Share & Trends Analysis Report By Product (Assays, Kits & Reagents, Systems), By Technology, By Application, By End-User, By Region, And By Segment Forecasts, 2025-2034

The Isothermal Nucleic Acid Amplification Technology Market Size is valued at USD 4.8 Bn in 2024 and is predicted to reach USD 12.0 Bn by the year 2034 at a 9.7% CAGR during the forecast period for 2025-2034.  Key Industry Insights & Findings from the Report:  Increasing disposable income and better healthcare facilities in emerging countries should boost the isothermal nucleic acid amplification technology industry. ...

Report ID: 2001  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Next-generation Mass Spectrometer Market Size, Share & Trends Analysis Report By Type (Hybrid & Single Mass Spectrometer), By Application (Pharmaceuticals, Biotechnology, Medical Research, Food and Beverage Testing), By End-User (Hospitals, Research Centers, Diagnostic Laboratories), By Region, And By Segment Forecasts, 2024-2031

The Next-generation Mass Spectrometer Market Size is valued at USD 2.04 billion in 2023 and is predicted to reach USD 3.57 billion by the year 2031 at a 7.5% CAGR during the forecast period for 2024-2031. Next-generation mass spectrometers are state-of-the-art analytical devices that provide enhanced sensitivity, resolution, speed, and versatility in comparison to earlier versions. They provide meticulous examination of intricate samples in di...

Report ID: 2608  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 170

RNA Editing Market Size, Share & Trends Analysis Report By Type of RNA (Messenger RNA Modifications, Transfer RNA Modification, Ribosomal RNA Modification), By Application (Cancer, Genetic Disorders, Temporary Maladies), By Technique (Insertion/Deletion, Deamination), By Region, And By Segment Forecasts, 2024-2031

The RNA Editing Market Size is valued at USD 15.2 billion in 2023 and is predicted to reach USD 23.1 billion by the year 2031 at a 5.60% CAGR during the forecast period for 2024-2031. RNA editing performs a crucial role in the nervous system, immune response, and cellular adaptation. It is a key focus in biomedical research for its potential in treating genetic disorders, cancer, and other diseases where RNA modification could offer therapeuti...

Report ID: 2882  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 165

Allogeneic Cell Therapy Market Size, Share & Trends Analysis Report By Type of Cell Therapy (Virus-Specific T-Cell, Stem Cell, Regulatory T-Cell), By Source of Cell, By Target Indication, By Therapeutic Area, Region And Segment Forecasts, 2023-2031

The Allogeneic Cell Therapy Market Size is valued at 997.36 Million in 2022 and is predicted to reach 2853.34 Million by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Enhancements in cell engineering and manufacturing processes are making allogenic cell therapies more accessible and effective. The increasing incidence of cancers like leukaemia and lymphoma,...

Report ID: 1084  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180